[Remission induction with vincristine and prednisolone alone in adult acute lymphocytic leukemia]. 1984

K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009279 Naphthacenes Polyacenes with four ortho-fused benzene rings in a straight linear arrangement. This group is best known for the subclass called TETRACYCLINES. Tetracenes,Benz(b)Anthracenes
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki
August 1976, Cancer,
K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki
December 1983, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki
January 1977, Oncology,
K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki
June 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki
July 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki
February 1977, Cancer research,
K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki
January 1979, Medical and pediatric oncology,
K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki
August 1974, Cancer,
K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki
February 2001, Hematology/oncology clinics of North America,
K Saito, and H Kajitani, and A Okuyama, and M Osato, and M Hara, and K Watanabe, and Y Dobashi, and T Yamazaki, and H Hamaguchi, and H Sakamaki
April 1973, Cancer,
Copied contents to your clipboard!